CHYMCHYMNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank11
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Latest
-10.16%
↓ 117% vs avg
Percentile
P11
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
61.22%
Historical baseline
PeriodValue
Q4 2025-10.16%
Q3 2025-80.07%
Q2 2025698.33%
Q1 2025-1.26%
Q4 2024-1.90%
Q3 20246.67%
Q2 20240.59%
Q1 20240.00%
Q4 20230.00%
Q3 20230.00%